Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The CER Daily Newsfeed, a newsletter from the National Pharmaceutical Council (NPC), cited a story on AJMC.com, the website of The American Journal of Managed Care® (AJMC®), about the Federal Trade Commission opening up an investigation into the business practices of the 6 largest pharmacy benefit managers. The story, "In Reversal, FTC Launches Inquiry Into PBM Industry," included interviews with the CEOs of the NPC as well as the Pontchartrain Cancer Center.
A piece by AJMC®'s sister site, Pharmacy Times®, cited a supplemental study published in AJMC®. The study, “Health Outcomes From an Innovative Enhanced Medication Therapy Management Model,” found that medication safety reviews were effective at improving annual health care costs, hospitalizations, emergency department visits, and mortality in Medicare beneficiaries targeted according to MedWise Risk Score.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Overall Incidence of HIV in Donated Blood Declined Despite Reduction in Deferral Periods
September 8th 2025Reducing the deferral period from 12 months to 3 months for those with high-risk behaviors did not increase the incidence of infectious diseases like HIV and hepatitis B appearing in donated blood.
Read More